Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany

摘要

Attention-deficit/hyperactivity disorder (ADHD) imposes a substantial burden on patients and their families.